Comparison of resection versus liver transplantation for intrahepatic cholangiocarcinoma: Past, present, and future directions

Sudha Kodali1,2,3, Ashton A Connor1,2,4,5, Souhail Thabet6, Elizabeth W Brombosz5, R Mark Ghobrial1,2,4,5
1Sherrie and Alan Conover Center for Liver Disease and Transplantation, Houston Methodist Hospital, Houston, TX 77030, USA
2JC Walter Jr Transplant Center, Houston Methodist Hospital, Houston, TX 77030, USA
3Department of Medicine, Weill Cornell Medical College, New York, NY, USA
4Department of Surgery, Houston Methodist Hospital, Houston, TX 77030, USA
5Department of Surgery, Weill Cornell Medical College, New York, NY, USA.
6School of Medicine, New Giza University, Giza, Egypt

Tài liệu tham khảo

Rizvi, 2013, Pathogenesis, diagnosis, and management of cholangiocarcinoma, Gastroenterology, 145, 1215, 10.1053/j.gastro.2013.10.013 Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 71, 209, 10.3322/caac.21660 Banales, 2020, Cholangiocarcinoma 2020: the next horizon in mechanisms and management, Nat Rev Gastroenterol Hepatol, 17, 557, 10.1038/s41575-020-0310-z Cronin, 2022, Annual report to the nation on the status of cancer, part 1: national cancer statistics, Cancer, 128, 4251, 10.1002/cncr.34479 Buckholz, 2020, Cholangiocarcinoma: diagnosis and management, Clin Liver Dis, 24, 421, 10.1016/j.cld.2020.04.005 Brindley, 2021, Cholangiocarcinoma, Nat Rev Dis Primers, 7, 65, 10.1038/s41572-021-00300-2 Clements, 2020, Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis, J Hepatol, 72, 95, 10.1016/j.jhep.2019.09.007 Lendvai, 2020, Cholangiocarcinoma: classification, histopathology and molecular carcinogenesis, Pathol Oncol Res, 26, 3, 10.1007/s12253-018-0491-8 Labib, 2019, Molecular pathogenesis of cholangiocarcinoma, BMC Cancer, 19, 185, 10.1186/s12885-019-5391-0 Connor, 2022, Intrahepatic cholangiocarcinoma: the role of liver transplantation, adjunctive treatments, and prognostic biomarkers, Front Oncol, 12, 10.3389/fonc.2022.996710 Weber, 2015, Intrahepatic cholangiocarcinoma: expert consensus statement, HPB (Oxford), 17, 669, 10.1111/hpb.12441 Kodali, 2022, Liver transplantation and intrahepatic cholangiocarcinoma: time to go forward again?, Curr Opin Organ Transplant, 27, 320, 10.1097/MOT.0000000000000983 Pichlmayr, 1995, Surgical treatment of cholangiocellular carcinoma, World J Surg, 19, 83, 10.1007/BF00316984 Pichlmayr, 1996, Surgical treatment in proximal bile duct cancer. A single-center experience, Ann Surg, 224, 628, 10.1097/00000658-199611000-00007 Casavilla, 1997, Hepatic resection and transplantation for peripheral cholangiocarcinoma, J Am Coll Surg, 185, 429, 10.1016/S1072-7515(97)00088-4 Roayaie, 1998, Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes, J Am Coll Surg, 187, 365, 10.1016/S1072-7515(98)00203-8 Weimann, 2000, Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma, Br J Surg, 87, 1182, 10.1046/j.1365-2168.2000.01532.x Ohtsuka, 2003, Extended hepatic resection and outcomes in intrahepatic cholangiocarcinoma, J Hepatobiliary Pancreat Surg, 10, 259, 10.1007/s00534-002-0724-8 Morimoto, 2003, Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma, J Hepatobiliary Pancreat Surg, 10, 432, 10.1007/s00534-002-0842-3 DeOliveira, 2007, Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution, Ann Surg, 245, 755, 10.1097/01.sla.0000251366.62632.d3 Endo, 2008, Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection, Ann Surg, 248, 84, 10.1097/SLA.0b013e318176c4d3 Konstadoulakis, 2008, Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome, Surgery, 143, 366, 10.1016/j.surg.2007.10.010 Tan, 2008, Surgical management of intrahepatic cholangiocarcinoma–a population-based study, Ann Surg Oncol, 15, 600, 10.1245/s10434-007-9627-x Sotiropoulos, 2009, R0 liver resections for primary malignant liver tumors in the noncirrhotic liver: a diagnosis-related analysis, Dig Dis Sci, 54, 887, 10.1007/s10620-008-0408-6 Ellis, 2011, Surgical treatment of intrahepatic cholangiocarcinoma: outcomes and predictive factors, HPB (Oxford), 13, 59, 10.1111/j.1477-2574.2010.00242.x Farges, 2011, Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group, Ann Surg, 254, 824, 10.1097/SLA.0b013e318236c21d Hong, 2011, Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center, Arch Surg, 146, 683, 10.1001/archsurg.2011.116 Wang, 2013, Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy, J Clin Oncol, 31, 1188, 10.1200/JCO.2012.41.5984 Doussot, 2015, Outcomes after resection of intrahepatic cholangiocarcinoma: external validation and comparison of prognostic models, J Am Coll Surg, 221, 452, 10.1016/j.jamcollsurg.2015.04.009 Lindnér, 2015, The impact of changed strategies for patients with cholangiocarcinoma in this millenium, HPB Surg, 2015, 10.1155/2015/736049 Spolverato, 2015, Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma?, Cancer, 121, 3998, 10.1002/cncr.29619 Tabrizian, 2015, Outcomes following resection of intrahepatic cholangiocarcinoma, HPB (Oxford), 17, 344, 10.1111/hpb.12359 Doussot, 2016, Recurrence patterns and disease-free survival after resection of intrahepatic cholangiocarcinoma: preoperative and postoperative prognostic models, J Am Coll Surg, 223, 493, 10.1016/j.jamcollsurg.2016.05.019 Jung, 2017, Clinicopathological features and prognosis of intrahepatic cholangiocarcinoma afterlLiver transplantation and resection, Ann Transplant, 22, 42, 10.12659/AOT.901504 Zhang, 2017, Perioperative and long-term outcome for intrahepatic cholangiocarcinoma: impact of major versus minor hepatectomy, J Gastrointest Surg, 21, 1841, 10.1007/s11605-017-3499-6 Bagante, 2019, Intrahepatic cholangiocarcinoma tumor burden: a classification and regression tree model to define prognostic groups after resection, Surgery, 166, 983, 10.1016/j.surg.2019.06.005 Si, 2019, Impact of anatomical versus non-anatomical liver resection on short- and long-term outcomes for patients with intrahepatic cholangiocarcinoma, Ann Surg Oncol, 26, 1841, 10.1245/s10434-019-07260-8 Spolverato, 2019, Management and outcomes among patients with mixed hepatocholangiocellular carcinoma: a population-based analysis, J Surg Oncol, 119, 278, 10.1002/jso.25331 De Martin, 2020, Analysis of liver resection versus liver transplantation on outcome of small intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in the setting of cirrhosis, Liver Transpl, 26, 785, 10.1002/lt.25737 Hu, 2020, Redefining conditional overall and disease-free survival after curative resection for intrahepatic cholangiocarcinoma: a multi-institutional, international study of 1221 patients, J Gastrointest Surg, 24, 2756, 10.1007/s11605-019-04472-x Hue, 2021, A comparison of surgical resection and liver transplantation in the treatment of intrahepatic cholangiocarcinoma in the era of modern chemotherapy: an analysis of the National Cancer Database, J Surg Oncol, 123, 949, 10.1002/jso.26370 Rafecas, 2021, Intrahepatic cholangiocarcinoma: prognostic factors for recurrence and survival in a series of 67 patients treated surgically at a single center, Cir Esp (Engl Ed), 99, 506, 10.1016/j.ciresp.2020.07.003 Hamad, 2022, Short- and long-term outcomes following robotic and open resection for intrahepatic cholangiocarcinoma: a national cohort study, Surg Oncol, 43, 10.1016/j.suronc.2022.101790 Kim, 2022, Intrahepatic cholangiocarcinoma: is there a role for liver transplantation?, Surgery, 171, 741, 10.1016/j.surg.2021.09.034 Lee, 2022, Disparities in curative treatments and outcomes for early stage intrahepatic cholangiocarcinoma in the United States, Cancer, 128, 3610, 10.1002/cncr.34436 Mazzaferro, 2020, Liver resection and transplantation for intrahepatic cholangiocarcinoma, J Hepatol, 72, 364, 10.1016/j.jhep.2019.11.020 Panayotova, 2021, The role of surgical resection and liver transplantation for the treatment of intrahepatic cholangiocarcinoma, J Clin Med, 10, 10.3390/jcm10112428 Edeline, 2020, Radioembolization plus chemotherapy for first-line treatment of locally advanced intrahepatic cholangiocarcinoma: a phase 2 clinical trial, JAMA Oncol, 6, 51, 10.1001/jamaoncol.2019.3702 Dai, 2023, The influence of resection margin width in patients with intrahepatic cholangiocarcinoma: a meta-analysis, World J Surg Oncol, 21, 16, 10.1186/s12957-023-02901-5 Kodali, 2021, Management of intrahepatic cholangiocarcinoma, J Clin Med, 10, 2368, 10.3390/jcm10112368 Sapisochin, 2022, Liver transplantation for intrahepatic cholangiocarcinoma: ready for prime time?, Hepatology, 18 Yokoyama, 1990, Liver transplantation in the treatment of primary liver cancer, Hepatogastroenterology, 37, 188 Ismail, 1990, Primary hepatic malignancy: the role of liver transplantation, Br J Surg, 77, 983, 10.1002/bjs.1800770908 Mazzaferro, 1996, Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis, N Engl J Med, 334, 693, 10.1056/NEJM199603143341104 Yao, 2001, Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival, Hepatology, 33, 1394, 10.1053/jhep.2001.24563 Silva, 2008, Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma, Liver Transpl, 14, 1449, 10.1002/lt.21576 Mazzaferro, 2009, Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis, Lancet Oncol, 10, 35, 10.1016/S1470-2045(08)70284-5 Victor, 2020, Outcomes of liver transplantation for hepatocellular carcinoma beyond the University of California San Francisco criteria: a single-center experience, Transplantation, 104, 113, 10.1097/TP.0000000000002835 Agopian, 2015, Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively treated patients, Ann Surg, 262, 536, 10.1097/SLA.0000000000001384 DiNorcia, 2020, Pathologic response to pretransplant locoregional therapy is predictive of patient outcome after liver transplantation for hepatocellular carcinoma: analysis from the US multicenter HCC transplant consortium, Ann Surg, 271, 616, 10.1097/SLA.0000000000003253 Duvoux, 2012, Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria, Gastroenterology, 143, 986, 10.1053/j.gastro.2012.05.052 Mazzaferro, 2018, Metroticket 2.0 model for analysis of competing risks of death after liver transplantation for hepatocellular carcinoma, Gastroenterology, 154, 128, 10.1053/j.gastro.2017.09.025 De Vreede, 2000, Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma, Liver Transpl, 6, 309, 10.1053/lv.2000.6143 Sudan, 2002, Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma, Am J Transplant, 2, 774, 10.1034/j.1600-6143.2002.20812.x Heimbach, 2004, Transplantation for hilar cholangiocarcinoma, Liver Transpl, 10, S65, 10.1002/lt.20266 O'Grady, 1988, Liver transplantation for malignant disease. Results in 93 consecutive patients, Ann Surg, 207, 373, 10.1097/00000658-198804000-00002 Ringe, 1989, The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence, Ann Surg, 209, 88, 10.1097/00000658-198901000-00013 Goldstein, 1993, Is liver transplantation indicated for cholangiocarcinoma?, Am J Surg, 166, 768, 10.1016/S0002-9610(05)80696-8 Goss, 1997, Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience, Ann Surg, 225, 472, 10.1097/00000658-199705000-00004 Meyer, 2000, Liver transplantation for cholangiocarcinoma: results in 207 patients, Transplantation, 69, 1633, 10.1097/00007890-200004270-00019 Shimoda, 2001, Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature, Liver Transpl, 7, 1023, 10.1053/jlts.2001.29419 Pascher, 2003, Intrahepatic cholangiocarcinoma: indication for transplantation, J Hepatobiliary Pancreat Surg, 10, 282, 10.1007/s00534-002-0731-9 Robles, 2004, Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma, Ann Surg, 239, 265, 10.1097/01.sla.0000108702.45715.81 Ghali, 2005, Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience, Liver Transpl, 11, 1412, 10.1002/lt.20512 Sotiropoulos, 2008, Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma: a single-center experience, Transplant Proc, 40, 3194, 10.1016/j.transproceed.2008.08.053 Fu, 2011, The role of liver transplantation for intrahepatic cholangiocarcinoma: a single-center experience, Eur Surg Res, 47, 218, 10.1159/000332827 Hu, 2011, Retrospective analysis of prognostic factors after liver transplantation for intrahepatic cholangiocarcinoma in China: a single-center experience, Hepatogastroenterology, 58, 1255, 10.5754/hge10704 Vallin, 2013, Unrecognized intrahepatic cholangiocarcinoma: an analysis of 993 adult cirrhotic liver explants, Clin Transplant, 27, 403, 10.1111/ctr.12108 Sapisochin, 2014, Very early" intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?, Am J Transplant, 14, 660, 10.1111/ajt.12591 Facciuto, 2015, Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation, Transplantation, 99, 151, 10.1097/TP.0000000000000286 Sapisochin, 2016, Liver transplantation for "very early" intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment, Hepatology, 64, 1178, 10.1002/hep.28744 Takahashi, 2016, Intrahepatic cholangiocarcinoma in the liver explant after liver transplantation: histological differentiation and prognosis, Ann Transplant, 21, 208, 10.12659/AOT.895936 Vilchez, 2016, Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database, HPB (Oxford), 18, 29, 10.1016/j.hpb.2015.10.001 Lee, 2018, Liver transplantation for intrahepatic cholangiocarcinoma, Liver Transpl, 24, 634, 10.1002/lt.25052 Lunsford, 2018, Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series, Lancet Gastroenterol Hepatol, 3, 337, 10.1016/S2468-1253(18)30045-1 Krasnodębski, 2020, Unsatisfactory long-term results of liver transplant in patients with intrahepatic cholangiocarcinoma, Transplant Proc, 52, 2463, 10.1016/j.transproceed.2020.02.095 Hara, 2021, Incidental intrahepatic cholangiocarcinoma in patients undergoing liver transplantation: a multi-center study in Japan, J Hepatobiliary Pancreat Sci, 28, 346, 10.1002/jhbp.896 Ito, 2022, A 3-decade, single-center experience of liver transplantation for cholangiocarcinoma: impact of era, tumor size, location, and neoadjuvant therapy, Liver Transpl, 28, 386, 10.1002/lt.26285 McMillan, 2022, Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma, Ame J Transpl, 22, 823, 10.1111/ajt.16906 Safdar, 2022, Outcomes after liver transplantation with incidental cholangiocarcinoma, Transpl Int, 35, 10802, 10.3389/ti.2022.10802 Hong, 2011, Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma, J Am Coll Surg, 212, 514, 10.1016/j.jamcollsurg.2010.12.005 Ren, 2020, A model for predicting post-liver transplantation recurrence in intrahepatic cholangiocarcinoma recipients, J Gastrointest Oncol, 11, 1283, 10.21037/jgo-20-209 Ziogas, 2021, Liver transplantation for intrahepatic cholangiocarcinoma: a meta-analysis and meta-regression of survival rates, Transplantation, 105, 2263, 10.1097/TP.0000000000003539 Krasnodębski, 2020, Analysis of patients with incidental perihilar cholangiocarcinoma: an old and a persistent burden for liver transplantation, Transplant Proc, 52, 2507, 10.1016/j.transproceed.2020.02.094 Abdelrahim, 2021, Transplant oncology: an evolving field in cancer care, Cancers (Basel), 13, 4911, 10.3390/cancers13194911 Cillo, 2019, Surgery for cholangiocarcinoma, Liver Int, 39, 143, 10.1111/liv.14089 Gruttadauria, 2021, Liver transplantation for unresectable intrahepatic cholangiocarcinoma: the role of sequencing genetic profiling, Cancers (Basel), 13, 10.3390/cancers13236049 Walter, 2017, Intratumoral heterogeneity of intrahepatic cholangiocarcinoma, Oncotarget, 8, 14957, 10.18632/oncotarget.14844 Dong, 2018, Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma, J Hepatol, 69, 89, 10.1016/j.jhep.2018.02.029 Chen, 2022, Multiomic analysis reveals comprehensive tumor heterogeneity and distinct immune subtypes in multifocal intrahepatic cholangiocarcinoma, Clin Cancer Res, 28, 1896, 10.1158/1078-0432.CCR-21-1157 Lin, 2022, Geospatial immune heterogeneity reflects the diverse tumor-immune interactions in intrahepatic cholangiocarcinoma, Cancer Discov, 12, 2350, 10.1158/2159-8290.CD-21-1640 Rauchfuß, 2022, Living donor liver transplantation for intrahepatic cholangiocarcinoma, Curr Oncol, 29, 1932, 10.3390/curroncol29030157 Hafeez Bhatti, 2020, Living donor liver transplantation for intra hepatic cholangiocarcinoma, Ann Med Surg (Lond), 57, 82, 10.1016/j.amsu.2020.07.028 Jonas, 2005, Extended indications in living-donor liver transplantation: bile duct cancer, Transplantation, 80, S101, 10.1097/01.tp.0000187106.29908.2b Mirallas, 2022, Advances in the systemic treatment of therapeutic approaches in biliary tract cancer, ESMO Open, 7, 10.1016/j.esmoop.2022.100503